Financial Architects (New Jersey)’s Genetic Technologies Ltd. GENE Stock Holding History

Financial Architects (New Jersey)’s Portfolio GENE Stock Details GENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-18	Closed	–	–	1514
2019 Q1	$0	Hold	18	–	–	﹤0.01%	1558
2018 Q4	$0	Hold	18	–	–	﹤0.01%	1526
2018 Q3	$0	Sell	18 -40	-69%	-$908	﹤0.01%	1531
2018 Q2	$1K	Buy	58 +40	+222%	+$946	﹤0.01%	1298
2018 Q1	$0	Hold	18	–	–	﹤0.01%	1625
2017 Q4	$0	Hold	18	–	–	﹤0.01%	1623
2017 Q3	$0	Hold	18	–	–	﹤0.01%	1628
2017 Q2	$0	Hold	18	–	–	﹤0.01%	1657
2017 Q1	$0	Hold	18	–	–	﹤0.01%	1645
2016 Q4	$0	Hold	18	–	–	﹤0.01%	1527
2016 Q3	$1K	Hold	18	–	–	﹤0.01%	1428
2016 Q2	$1K	Buy	+18	New	+$829	﹤0.01%	1412

Other funds holding GENE

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AGU

Alpine Group USVI St. Thomas, U.S. Virgin Islands $23.4M AUM

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Financial Architects (New Jersey)'s GENE Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of Genetic Technologies Ltd. (GENE) in Q2 2019, closing a stake of 18 shares.

Financial Architects (New Jersey) first reported a position in GENE in Q2 2016 and held it in 12 quarters. The position peaked at $1K in Q2 2018. 13 funds tracked by Wall St. Rank hold GENE as of Q2 2019.

Financial Architects (New Jersey) reported no remaining Genetic Technologies Ltd. position as of Q2 2019 after selling out during the quarter.
Financial Architects (New Jersey) sold 18 Genetic Technologies Ltd. shares in Q2 2019.
Financial Architects (New Jersey) first reported a position in Genetic Technologies Ltd. in Q2 2016 and held it in 12 quarters.
Financial Architects (New Jersey)'s Genetic Technologies Ltd. position peaked at $1K in Q2 2018.
13 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.